Overview

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP

Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to concurrently evaluate whether adjunct treatment with corticosteroids in children hospitalized with CAP is more effective in terms of the proportion of children reaching clinical stability and whether such adjunct treatment is no worse in terms of CAP relapse.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
Swiss National Fund for Scientific Research
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate